Načítá se...
SEOM clinical guidelines for the treatment of Hodgkin’s lymphoma
Hodgkin lymphoma (HL) is an uncommon B cell lymphoid malignancy representing approximately 10–15 % of all lymphomas. HL is composed of two distinct disease entities; the more commonly diagnosed classical HL and the rare nodular lymphocyte-predominant HL. An accurate assessment of the stage of diseas...
Uloženo v:
| Vydáno v: | Clin Transl Oncol |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer Milan
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4689754/ https://ncbi.nlm.nih.gov/pubmed/26497354 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12094-015-1429-1 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|